Christian Marsolais

Christian Marsolais

Company: Theratechnologies Inc.

Job title: SrVP & CMO


Moving From Bench to Bedside: Transitioning the Novel PDC TH1902 From the Preclinical to the Clinical Setting 2:30 pm

Sortilin is a novel receptor overexpressed in cancer, whose normal function as a scavenger receptor can be exploited to rapidly transport cytotoxic drugs into cancer cells Learn about the validation of the unique MoA and kinetics of internalization of TH1902 into the cancer cells Gain insight into the status of the Phase I Study (Part…Read more

day: Scientific Program Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.